Care for Women Choosing Medication Abortion

Nurse Practitioner,  Oct 2004  by Taylor, Diana,  Hwang, Ann C,  Stewart, Felicia H

• E-mail
• Print
• Link

6. Jones BS, Heller S: Providing medical abortion: legal issues of relevance to providers. J Am Med Women's Assoc 2000;55(3):145-50.

7. Borgmann CE, Jones BS: Legal issues in the provision of medical abortion. Am J Obstet Gynecol 2000;183(2):S84-S94.

8. McKinley C, Thong KH, Baird DT: The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 1993;3(9):1502-5.

9. Ashok PW, Penney GC, Flett GM, et al.: An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998;13(10):2962-5.

10. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation: Termination of pregnancy with reduced doses of mifepristone. Br Med J 1993;307(6903):532-7.

11. Schaff EA, Stadalius LS, Eisinger SH, et al.: Vaginal misoprostol administered at home after mifepristonc (RU486) for abortion. J Fam Pract 1997;44(4):353-60.

12. Schaff EA, Eisinger SH, Stadalius LS, et al.: Low-dose mtfeprislone 200 ing and vaginal misoprostol for abortion. Contraception 1999;59(1):1-6.

13. Schaff EA, Fielding SL, Westhoff C: Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy. Contraception 2002;66(4):247-50.

14. El-Refaey H, Rajasckar M, Abdalla M, et al.: Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995;322(15):983-7.

15. El-Refaey H, Templeton A; Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route. Contraception 1994;49(2):111-4.

16. Schaff EA, Fielding SL, Westhoff C: Randomized trial of oral versus vaginal misoprostol at one day after mifepristonc for early medical abortion. Contraception 2001;64(2):81-5.

17. Schaff EA, Fielding SL, Westhoff C, el al.: Vaginal misoprostol administered 1, 2, or 3 days after mifepristonc for early medical abortion: a randomized trial. JAMA 2000;284(15):1948-1953.

18. Henshaw RC, Naji SA, Russell IT, et al.: Comparison of medical abortion and surgical vacuum aspiration: women's preferences and acceptability of treatment. Br Med J 1993;307(6906):714-717.

19. Winikoff B, Ellertson C, Elul B, et al.: Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol: results of a large multicenter trial in the United States. Arch Fam Med.1998;7(4):360-366.

20. Winikoff B, Sivin I, Coyaji KJ, et al: Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol 1997; 176(2):431-437.

21. Jensen JT, Harvey SM, Beckman LJ: Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study. Am J Obstet Gynecol 2000;182(6):1292-99.

22. Spitz IM, Bardin CW, Benton L, et al.: Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338(18):1241-7.